Andrea Lobo,  —

Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.

Articles by Andrea Lobo

Adrenal gland tumor surgery safe in pregnant woman: Case report

A pregnant woman underwent a successful laparoscopic adrenalectomy, a minimally invasive surgery to remove tumors in the adrenal glands, for Cushing’s syndrome which was caused by such a tumor and resolved, according to a case report. Although it is the standard treatment for adrenal tumors, laparoscopic adrenalectomy is not commonly done…

Case of exogenous Cushing’s sparks warnings of herbal supplement

A 44-year-old man developed exogenous, or treatment-related, Cushing’s syndrome, after taking an herbal supplement called Nhan Sam Tuyet Lien, which contained undisclosed amounts of glucocorticoids, a case study reports. His symptoms eased after he stopped taking the supplement and started taking prednisone. “This case highlights the importance of history taking…

Tumor removal surgery seen to benefit Cushing’s patients in study

While people with Cushing’s syndrome often experience hypertension, or high blood pressure, and diabetes — two conditions that put them at higher risk of developing cardiovascular diseases — tumor removal surgery was found to ease these conditions in a new study from Tunisia. Indeed, most patients saw improvements within one…

First patient enters extension study of SPI-62

The first patient has opted to enter the open-label extension study of a Phase 2 trial testing SPI-62 in people with adrenocorticotropic hormone (ACTH)-dependent forms of Cushing’s syndrome, including Cushing’s disease. The announcement was made by SPI-62’s developer, Sparrow Pharmaceuticals, which is conducting a Phase 2 trial called…

Pulmonary embolism may be first symptom of Cushing’s: Report

A 37-year-old woman diagnosed with Cushing’s disease following childbirth experienced a pulmonary embolism — a blockage in blood flow to the lungs that’s generally caused by blood clots — as one of the first symptoms of the rare disorder. According to clinicians, her case highlights that pulmonary embolism may…

Type of transsphenoidal surgery safe, tied to Cushing’s remission

A type of minimally invasive surgery to remove pituitary tumors through the nose, called endoscopic transsphenoidal surgery, was found to be safe and led to remission from Cushing’s disease, with patients seeing no recurrences, a study in China reports. The procedure involved identifying pituitary and tumor layers before the…

Anxiety misdiagnosis leads to serotonin syndrome in woman

A 47-year-old woman with Cushing’s disease was initially misdiagnosed with an anxiety disorder, ultimately leading to her developing additional complications, scientists in China reported. The woman was diagnosed with Cushing’s disease after an ineffective psychiatric intervention, but continued taking high doses of psychiatric medications after surgery to remove a…

Cushing’s patients report high disease burden, despite treatment

People with Cushing’s syndrome have a high disease burden linked to persistent symptoms of weight gain, pain, and anxiety, despite being treated, a recent study reported. These observations highlight the need for interventions that address these persistent symptoms and “underscore the importance of the patient’s perspective in clinical decision making…